IMMUNOGENICITY OF FIMBRILLIN FROM B. GINGIVALIS

来自牙龈芽孢杆菌的纤丝蛋白的免疫原性

基本信息

项目摘要

The specific immune response to bacterial infections have been shown to involve the generation of both cellular and humoral immunity directed against bacterial antigens. The activation of these immunologic effector mechanisms is accomplished by the interaction of inducer T cells with immunologic effector cells, either B cells, T cells, or macrophages. Severe adult Periodontal disease is a disorder characterized by the inability to resolve the infection by a pathogen or pathogens within the gingival margins and the periodontium which results in a chronic destructive immunologic response. Bacteroides Gingivalis, a black pigmented gram negative bacteria, has been implicated as one of the major causative agents in severe adult periodontal disease. This proposal describes studies that investigate the nature and specificity of T lymphocyte response to fimbrillin, the constitutive protein of fimbriae of B. Gingivalis strain 381. T cells recognize antigen on antigen-presenting cells as peptides associated with self-molecules encoded by the Major Histocompatibility Complex. Therefore, the immunogenicity of whole Bg, bacterial fimbrae, or purified fimbrillin molecules will be analyzed, and factors influencing the immunogenicity of these molecules compared. Small -synthetic peptides of the fimbrillin molecule from B. Gingivalis strain 381 will be generated based on the predicted amino acid sequence from the cloned fimbrillin gene, and these peptides will be analyzed in order to identify specific amino acid sequences, i.e. epitopes, on the fimbrillin molecule which induce immunologic responses in T lymphocytes. The nature of the T cell response to immunologic epitopes will be analyzed for its specificity for MHC-linked molecules, its production of inflammatory and humoral lymphokines, and its ability to respond to Bg, fimbrae, or fimbrillin antigen on a variety of different antigen presenting cells. Understanding the factors which influence the immune response to immunogenic epitopes on fimbrillin will significantly enhance our understanding of how T cells respond to bacterial antigens in .vivo, and will aid in designing better immunologic -approaches to the treatment of periodontal disease.
对细菌感染的特异性免疫反应已被证明

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Patrick Michael Flood其他文献

Patrick Michael Flood的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Patrick Michael Flood', 18)}}的其他基金

Inhibition of IkK to treat lethal Graft-vs.-Host Disease
抑制 Ikk 可治疗致命的移植物抗宿主病
  • 批准号:
    7883853
  • 财政年份:
    2009
  • 资助金额:
    $ 17.23万
  • 项目类别:
NF-kB Inhibition of Lung Ischemia Repurfusion Injury
NF-kB对肺缺血再灌注损伤的抑制作用
  • 批准号:
    7750074
  • 财政年份:
    2009
  • 资助金额:
    $ 17.23万
  • 项目类别:
Blockade of NF-kappaB for Prevention/Treatment of GVHD
阻断 NF-κB 用于预防/治疗 GVHD
  • 批准号:
    7108055
  • 财政年份:
    2006
  • 资助金额:
    $ 17.23万
  • 项目类别:
Inhibition of IkK to treat lethal Graft-vs.-Host Disease
抑制 Ikk 可治疗致命的移植物抗宿主病
  • 批准号:
    7481353
  • 财政年份:
    2006
  • 资助金额:
    $ 17.23万
  • 项目类别:
Inhibition of IkK to treat lethal Graft-vs.-Host Disease
抑制 Ikk 可治疗致命的移植物抗宿主病
  • 批准号:
    7643877
  • 财政年份:
    2006
  • 资助金额:
    $ 17.23万
  • 项目类别:
ROLE OF NF-KB IN T CELL INFLAMMATION
NF-KB 在 T 细胞炎症中的作用
  • 批准号:
    6654111
  • 财政年份:
    2002
  • 资助金额:
    $ 17.23万
  • 项目类别:
ROLE OF NF-KB IN T CELL INFLAMMATION
NF-KB 在 T 细胞炎症中的作用
  • 批准号:
    6644959
  • 财政年份:
    2001
  • 资助金额:
    $ 17.23万
  • 项目类别:
COMPREHENSIVE CENTER FOR INFLAMMATORY DISORDERS
炎症性疾病综合中心
  • 批准号:
    6523867
  • 财政年份:
    1999
  • 资助金额:
    $ 17.23万
  • 项目类别:
COMPREHENSIVE CENTER FOR INFLAMMATORY DISORDERS
炎症性疾病综合中心
  • 批准号:
    6175888
  • 财政年份:
    1999
  • 资助金额:
    $ 17.23万
  • 项目类别:
ROLE OF NF-KB IN T CELL INFLAMMATION
NF-KB 在 T 细胞炎症中的作用
  • 批准号:
    6493982
  • 财政年份:
    1999
  • 资助金额:
    $ 17.23万
  • 项目类别:

相似海外基金

The molecular basis of T cell receptor cross-reactivity between MHC and MR1
MHC 和 MR1 之间 T 细胞受体交叉反应的分子基础
  • 批准号:
    DP240102905
  • 财政年份:
    2024
  • 资助金额:
    $ 17.23万
  • 项目类别:
    Discovery Projects
Machine Learning of Disease Biomarkers from B and T cell Receptor Repertoires
来自 B 和 T 细胞受体库的疾病生物标志物的机器学习
  • 批准号:
    23K28188
  • 财政年份:
    2024
  • 资助金额:
    $ 17.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
CAREER: Understanding the Impact of Dephosphorylation Kinetics and Adapter Specificity on Synthetic T Cell Receptor Signaling and Function
职业:了解去磷酸化动力学和接头特异性对合成 T 细胞受体信号传导和功能的影响
  • 批准号:
    2339172
  • 财政年份:
    2024
  • 资助金额:
    $ 17.23万
  • 项目类别:
    Continuing Grant
Special Public T Cell Receptor Sequences that Predict Outcomes for Cancer Patients
预测癌症患者预后的特殊公共 T 细胞受体序列
  • 批准号:
    10577518
  • 财政年份:
    2023
  • 资助金额:
    $ 17.23万
  • 项目类别:
Machine Learning of Disease Biomarkers from B and T cell Receptor Repertoires
来自 B 和 T 细胞受体库的疾病生物标志物的机器学习
  • 批准号:
    23H03498
  • 财政年份:
    2023
  • 资助金额:
    $ 17.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Impact of T cell receptor signaling on memory CD8+ T cell stemness
T 细胞受体信号传导对记忆 CD8 T 细胞干性的影响
  • 批准号:
    10676407
  • 财政年份:
    2023
  • 资助金额:
    $ 17.23万
  • 项目类别:
T cell receptor cross-reactivity and structural basis of virus immune escape
T细胞受体交叉反应性和病毒免疫逃逸的结构基础
  • 批准号:
    22KK0277
  • 财政年份:
    2023
  • 资助金额:
    $ 17.23万
  • 项目类别:
    Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))
T-cell receptor mimic affinity reagent generation using an in vivo novel immunogen strategy
使用体内新型免疫原策略生成 T 细胞受体模拟亲和试剂
  • 批准号:
    10599584
  • 财政年份:
    2023
  • 资助金额:
    $ 17.23万
  • 项目类别:
Mechanical regulation of T cell receptor and co-receptor responses in cancer immunotherapy
癌症免疫治疗中 T 细胞受体和辅助受体反应的机械调节
  • 批准号:
    10530023
  • 财政年份:
    2022
  • 资助金额:
    $ 17.23万
  • 项目类别:
Inhibition of T-cell Receptor Signaling for Treatment of Adult T-cell Leukemia Lymphoma
抑制 T 细胞受体信号转导治疗成人 T 细胞白血病淋巴瘤
  • 批准号:
    10684172
  • 财政年份:
    2022
  • 资助金额:
    $ 17.23万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了